Chemical and enzymatic incorporation of N2-(p-n-butylphenyl)-2\u27-deoxyguanosine into an oligodeoxyribonucleotide by Misra, Hemant K. et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Open Access Articles Open Access Publications by UMMS Authors 
1992-09-11 
Chemical and enzymatic incorporation of N2-(p-n-butylphenyl)-2'-
deoxyguanosine into an oligodeoxyribonucleotide 
Hemant K. Misra 
University of Massachusetts Medical School 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/oapubs 
 Part of the Life Sciences Commons, and the Medicine and Health Sciences Commons 
Repository Citation 
Misra HK, Khan NN, Agrawal S, Wright GE. (1992). Chemical and enzymatic incorporation of N2-(p-n-
butylphenyl)-2'-deoxyguanosine into an oligodeoxyribonucleotide. Open Access Articles. Retrieved from 
https://escholarship.umassmed.edu/oapubs/1709 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access Articles 
by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
Nucleic Acids Research, Vol. 20, No. 17 4547-4551
Chemical and enzymatic incorporation of N2-(p-n-
butylphenyl)-2'-deoxyguanosine into an
oligodeoxyribonucleotide
Hemant K.Misra, Naseema N.Khan, Sudhir Agrawal1 and George E.Wright*
Department of Pharmacology, University of Massachusetts Medical School, Worcester, MA 01655
and 1Worcester Foundation for Experimental Biology, Shrewsbury, MA 01545, USA
Received May 20, 1992; Revised and Accepted August 7, 1992
ABSTRACT
An 1 8mer oligodeoxyribonucleotide containing a
N2-(p-n-butylphenyl)-2'-deoxyguanosine (BuPdG)
residue at the 3' end has been synthesized by both
chemical and enzymatic methods. Chemical synthesis
involved attachment of 5'-DMT-BuPdG as the 3'-H-
phosphonate to uridine-controlled pore glass (CPG),
followed by extension via H-phosphonate chemistry.
After oxidation of the backbone, deprotection of bases,
and removal from CPG, the uridine residue was
removed by periodate cleavage and i-elimination. The
resulting oligomer 3'-phosphate was digested with
alkaline phosphatase to give the free BuPdG-18mer.
E.coli DNA polymerase I (Klenow) incorporated
BuPdGTP at the 3' end of the corresponding 17mer
primer annealed to a complementary 29mer template,
and the properties of this product were identical to
those of chemically synthesized BuPdG-18mer. E.coll
DNA polymerase I (Klenow) was unable to extend the
BuPdG-1 8mer, and the 3' to 5' exonuclease activity of
the enzyme was unable to remove the modified
nucleotide.
INTRODUCTION
N2-(p-n-Butylphenyl)-2 '-deoxyguanosine 5' -triphosphate
(butylphenyl-dGTP, BuPdGTP) is a potent and selective inhibitor
of eukaryotic DNA polymerase at and a-like DNA polymerases
such as bacteriophage T4 DNA polymerase.1-4 In contrast,
E. coli DNA polymerase I (pol I) has been found to be quite
insensitive to this nucleotide.4 BuPdGTP is not a substrate for
DNA polymerase a, but appears to be a substrate for the T4
enzyme.2 Thus, the basis for sensitivity to BuPdGTP among
DNA polymerases may be complex.
Among a series of N2-substituted dGTP derivatives, we
recently reported that N2-phenyl-dGTP (and BuPdGTP) could
be incorporated by E. coli DNA polymerase I into an
oligodeoxyribonucleotide primer in place of dGTP, but that
significant chain termination occurred at the incorporation sites.5
In order to study the effects of butylphenyl-dG residues at the
primer terminus on BuPdGTP-sensitive (pol a, T4 pol) and
insensitive (pol I) enzymes, and to have authentic material for
comparison of the properties of enzymatically incorporated
BuPdGTP, we have synthesized chemically a 3'-BuPdG-
oligomer. We show that the properties of this oligomer annealed
to a complementary template are identical with those of the
oligomer into which BuPdGTP has been incorporated by pol l,
namely that the BuPdG-oligomer cannot be extended with the
next substrate and cannot be degraded by the 3' to 5' exonuclease
activity of pol I.
MATERIALS AND METHODS
Syntheses
General. NMR spectra were determined with a Varian Unity 300
instrument. Chemical shifts in 'H spectra at 300 MHz are
referred to internal TMS, and in 31p spectra at 121.4 MHz to
a capillary of 1% phosphoric acid.
S '- (Dimethoxytrityl)-N2- (p-n-butylphenyl)-9- (2-deoxy-,3-D-
ribofiuranosyl)guanine (5'-DMT-BuPdG, 2). Triethylamine (200
AL) was added to a solution of N2-(p-n-Butylphenyl-9-(2-deoxy-
f3-D-ribofuranosyl)guanine (BuPdG, 1)6 (145 mg, 0.363 mmol),
dimethoxytrityl chloride (493 mg, 1.45 mmol) and
4-(dimethylamino)pyridine (1.3 mg) in dry pyridine (5 mL). After
stirring for 2 hr at rt under Ar, the solution was poured into sat.
NaHCO3 solution. This mixture was extracted with ethyl acetate
(3 x 5 mL), and the dried (Na2SO4) organic phase was
concentrated and the residue applied to a silica gel column
(51 x2 cm). After washing with CHCl3 the product was eluted
with CHCl3:MeOH (20:1). After evaporation of solvents the
product was crystallized from MeOH giving 161 mg (61 %) of
2 as colorless crystals, mp 165-170°C. Anal. (C41H43N506):
Calcd. C, 70.17; H, 6.18; N, 9.98. Found C, 69.98; H, 6.17;
N, 9.90. 'H NMR (Me2SO-d6) 6 6.26 (t, 1'H), 4.37 (m, 3'H),
5.31 (d, exch, 3'-OH), 3.2 (d, 5',5"H).
5'- (Dimethoxytrityl)-N2- (p-n-butylphenyl)-9- (2-deoxy-,B-D-
ribofuranosyl)guanine-3 '-H-phosphonate, triethylammonium salt
(3). 1,2,4-Triazole (21.7 mg, 1.18 mmol) was added to a stirred
solution of PCl3 (48.9 mg, 0.35 mmol) and N-
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methylmorpholine (39.2 IL, 3.6 mmol) in dry CH2C12, and the
mixture was stirred for 2 h at rt under argon.7 The mixture was
cooled to -5°C, and a solution of 2 (50 mg, 0.71 mmol) in dry
CH2CI2 (3 mL) was added slowly. After 20 min at -5°C the
reaction mixture was poured into 10 mL of 1M triethylammonium
bicarbonate (TEAB, pH 8.5). The organic layer was separated,
and the aqueous phase was extracted with CH2C12 (10 mL). The
combined organic extracts were dried (Na2SO4) and the solvents
removed to give a gum. This material was dissolved in CHC13
(0.5 mL), and the solution was slowly added to pentane (25 mL)
cooled to -78°C. The colorless precipitate was collected by
filtration to give 60 mg (97%) of 3. Analytically pure product
was obtained by silica gel chromatography (10 x 2 cm; prepared
in 1% NEt3 in CHC13) and elution with 5% MeOH in CHC13
(81% recovery). Anal. (C47H59N608P): Calcd. P, 3.57. Found
P, 3.25. NMR (CD3CN:C6D5N, 1:1): 'H 6 7.17 (d, J=608.5
Hz, PH), 6.46 (t, l'H), 5.29 (m, 3'H), 3.52 (d, 5',5"-H). 31p
6 -3.05, IJPH=608.5 Hz, 4JPH=9.15 Hz.
3'-BuPdG-l8mer (9). The oligodeoxyribonucleotide was
synthesized via the H-phosphonate approach using an automated
DNA synthesizer (8700 model, Millipore, Milford, MA).
Synthesis was carried out on a 1 Amol scale using the H-
phosphonate coupling cycle.8 The first step coupled the BuPdG-
H-phosphonate (3) to uridine-controlled pore glass (CPG) support
(Glen Research, Herndon, VA) with pivaloyl chloride catalyst.
The required oligonucleotide sequence was assembled onto the
CPG-bound dinucleoside H-phosphonate (4) with 5'-DMT-2'-
deoxyribonucleoside-3'-H-phosphonates (4.0 mg/coupling).7,8
At the end of the assembly, the CPG-bound oligonucleotide
H-phosphonate (5) was oxidized with 2% 12 in pyridine:water
(98:2, v:v) for 10 min to generate the phosphodiester backbone.
Deprotection was carried out in conc NH40H for 10 hr at 55°C.
Ammonia was removed by evaporation, and the solid mass of
6 was suspended in 1 mL of water.
The crude oligonucleotide suspension was treated with sodium
periodate in sodium acetate buffer, pH 5.5, for 30 min in the
dark at ambient temperature. The progress of the reaction was
followed by reverse phase HPLC9 (see below). The reaction
mixture was desalted using a Sep-pak C-18 cartridge (Waters
Associates, Milford, MA), and the eluate containing the
dialdehyde form of the oligonucleotide (7) was treated with
cyclohexylamine to remove uridine by $-elimination. The
product, the 3'-phosphate of the oligodeoxyribonucleotide (8),
was incubated with bacterial alkaline phosphatase to obtain the
free BuPdG-18mer (9), which was purified by electrophoresis
in a 8M urea-polyacrylamide gel.
HPLC. Analytical HPLC was carried out using a Waters 600E
system controller, 745 data module and 481 UV-VIS detector,
and a Novapak C-18 column with a RCM 100 cartridge holder.
Buffers were: A, 100 mM ammonium acetate; B, 20% buffer
A in acetonitrile. The gradient used was 0-30% buffer B over
25 min and 30-100% buffer B over 15 min at a flow rate of
1.5 ml min-'. Retention times were: oligonucleotide dialdehyde
(7), 19.4 min; BuPdG-18mer-3'-phosphate (8), 20.2 min.
Enzyme assays
Materials. E. coli DNA polymerase I, Klenow fragment, was the
sequencing grade obtained from Boehringer Mannheim. Terminal
deoxyribonucleotidyl transferase (TdT) was obtained from New
England Nuclear. Activated DNA was prepared as described."'
Operon Technologies Inc. supplied the 17mer primer (M13
universal primer SPOO1- 1) and synthesized the 29mer template;
sequences of these oligomers are shown in Fig 2.
5'-[32P]-labelling of primers with polynucleotide kinase and
annealing of primer:templates were done as described.2
Standard pol I assay. Assays were done in a mixture of 30 mM
Tris-HCl, pH 7.5, 20% glycerol, 4 mM DTT and 10 mM
Mg(OAc)2. Assay mixtures (25 ,uL each) contained 25 yIM
dCTP, dGTP and dATP and 10 IM [3H]dTTP (1250
cpm/pmol), 400 ig/mL activated DNA and 0.5 unit of E.coli
pol I, Klenow fragment. Truncated assays were identical except
for the omission of dGTP. Processing and counting of acid-
precipitable material were done as described."I
Primer extension assay. Reactions were done in 25 ,uL of an assay
mix containing 30 mM Tris HC1, pH 7.5, 5% glycerol, 4 mM
DTT, 10 mM Mg(OAc)2 and 1.2 /M of labelled
primer:template, with the addition of appropriate substrates.
Assays for approximate Km and kinetic determinations contained
0.35 AM primer:template. Reactions were initiated by addition
of 0.1 -0.5 units of pol l, and the mixtures were incubated at
30°C for 10 min. Procedures for termination and analysis of
reaction products by 8M urea-polyacrylamide gel electrophoresis
were as described.2 Assays with TdT and analysis of products
were done as described.2
RESULTS
Chemistry
We used H-phosphonate chemistry and a uridine-controlled pore
glass (CPG) conjugate for synthesis of an oligomer containing
the N2-(p-n-butylphenyl)dGuo residue at the 3' position (Chart
I). This strategy was dictated, in part, by our inability to prepare
the 3'-hemisuccinate of 5'-DMT-BuPdG for direct attachment
to aminoalkyl-CPG (data not shown). 5'-DMT-BuPdG (2) and
its 3'-H-phosphonate (3) were synthesized by standard
methods.7 The H-phosphonate was obtained in 97% yield and
was characterized by IH and 31P NMR and P analysis (see
Materials and Methods).
Oligodeoxyribonucleotide synthesis was performed on a DNA
synthesizer by reported procedures.7,8 Compound 3 was coupled
to uridine-CPG with pivaloyl chloride (Chart I, step c). The chain
was elongated with protected 5'-DMT-deoxynucleoside 3'-H-
phosphonates, and the CPG-bound oligonucleoside-H-
phosphonate was oxidized with iodine (step d) to generate the
oligonucleotide phosphodiester, 5. (The boldface sequence in
structure 5, Chart I, implies protected bases.) After deprotection
of the bases and release from CPG (step e), the free uridine-
capped oligonucleotide (6) was treated with periodic acid at room
temperature (step f) to generate the dialdehyde, 7.9 After
desalting on a C-18 column the dialdehyde was treated with
cyclohexylamine (step g) to effect f-elimination to yield the
BuPdG- 1 8mer as the 3 '-phosphate, 8. After dephosphorylation
with bacterial alkaline phosphatase, the BuPdG-18mer, 9, was
purified by denaturing polyacrylamide gel electrophoresis. The
preparation was done on a 1 timole scale, and coupling efficiency
was 98%.
The ability of the BuPdG-18mer to serve as a substrate for
dNTP incorporation was shown by the results of extension
reactions with TdT. Incubation of BuPdG- 18mer with TdT in
the presence of dGTP or BuPdGTP at 50 pM for 60 min at 35°C
gave products as shown in Figure 1. The oligonucleotide gave
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Chart I
BuPG
D~MTl0<Oj
OH
(2)
BuPG
DMT-O- j
0b.
H-P=O
0-
HNEt3'
(3)
C.
BuPG
DMT-O
0
H-P=O
Ura
(4) o
Ac, CPG
5'-GTAAAACGACGGCCAGT-O
-O-P=O
BuPG
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OH OH
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-O-P=O
BuPG
(8) o
-o-P=O
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5'-GTAAAACGACGGCCAGT-O
-O-P=O
BuPG
0
°°1
d. -O-P=O
Ura
(5) 0 O
Ac, CPG
5'-GTAAAACGACGGCCAGT40
.O-P=O
Ura
(7)
0 0
h. 5-d(GTAAAACGACGGCCAGTBuPG).3'.OH
BUPdG-18mer
(9)
Figure 1. Extension of BuPdG-lI8mer by TdT. Reactions (10 AL) containing 3.6
1cM [5'-32P]BuPdG-18mer and 0.25 units of terminal deoxyribonucleotidyl
transferase were incubated2for h at 350C, and products were analyzed by 8M
urea-PAGE as described.2 Lane A, + 50 AtM dGTP. Lane B, + 50 AtM
BuPdGTP. Lane C, BuPdG-18mer alone.
Primcir (17mier) 0
5' GCTAAACGACGGCCAGT
3' CATTTTGCTGCCGGTCACATGCCGATCCC5'
T'cmlplitc (29niicrI)
a ladder of products with dGTP (lane A), but only supported
extension by one molecule of BuPdGTP (lane B). These results
indicate both that the terminal 3'-OH group of the BuPdG-l8mer
is free and that it can support dNTP incorporation.
BuPdGTP is a substrate for E.coli pol I
The primer-template illustrated in Figure 2 was used to monitor
incorporation of nucleotides by E. coli pol l, Klenow fragment.
5'-32P-labelled 17mer primer, prepared with ['y-32P]ATP and
polynucleotide kinase, was annealed to 29mer template as
described previously.2 After incubation with pol I at 30°C for
10 minutes, the reaction mixtures were applied to a 8M urea-12%
polyacrylamide gel and subjected to electrophoresis as
described.2 As illustrated in Figure 2, incubation with all dNTPs
at 10,uM produced fully copied 29mer product (lane J). Inclusion
of 2 AM dGTP alone (lane C) or 2 yM each of dGTP and dTTP
(lane E) resulted in nearly exclusive conversion of primer to the
expected 18mer and l9mer, respectively. When 17mer:29mer
was incubated with pol I and 100 yM BuPdGTP alone, a product
migrating at nearly the same position as the 18mer was observed
(lane D). This produict appeared at the same position as 5/_32p-
labelled BuPdG-l8mer, synthesized as described above (lane B).
Migration of the BuPdG- 18mer in the gel was slightly slower
than that of the conventional dG-l8mer (Figure 2 and results not
shown).
Apparent Km values for pol I-catalyzed incorporation of dGTP
and BuPdGTP, defined as the concentrations of the substrates
required to convert 50% of starting primer to product in 10
minutes at 30°C, were determined in single site extension
.* 0@. *:m *. ..
_ 0. _ 4
A 13 C I) E E ( II J
Figure 2. Primer extension reactions with E. coli pol I. Reactions were done as
described in Materials and Methods, and utilized as primer:templates either
5'-[32P]-labelled-17mer:29mer or 5'-[32P]-labelled-BuPdG-18mer:29mer and pol
I, and with the additions indicated. Products were analyzed by 8M urea-PAGE.
Lanes A and I, 17mer, no dNTPs. Lane B, BuPdG-18mer, no dNTPs. Lane
C, 17mer plus 2 $M dGTP. Lane D, 17mer plus 100 IAM BuPdGTP. Lane E,
17mer plus 2 AM dGTP and dTTP. Lane F, 17mer plus 100 tiM BuPdGTP and
2 jAM dTTP. Lane G, BuPdG-18mer plus 2 1cM dTTP. Lane H, 17mer plus
BuPdG-18mer, no dNTPs. Lane J, 17mer plus 25 ,uM dGTP, dATP, dCTP and
dTTP.
reactions. Quantitation of starting and product oligomers derived
from [32P]-labelled 17mer:29mer, separated on denaturing gels
and measured with a Betascope analyzer, revealed apparent Km
values of 0.8 and 2.0 yiM for dGTP and BuPdGTP, respectively.
However, the rate of incorporation ofBuPdGTP was considerably
slower than that of dGTP when substrates were present at
'3xKm' concentrations. At 30°C the half time for conversion
of 17mer to BuPdG-18mer in the presence of 6 AM BuPdGTP
in primer extension reactions was 5 minutes. The half time for
conversion of 17mer to 18mer with 2.5,^M dGTP was less than
BuPdG
(1)
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1 minute at this temperature. These results indicate similar affinity
of the nucleotides for the pol I-primer:template complex, but a
significantly reduced rate of incorporation of the synthetic
nucleotide compared to the natural substrate.
BuPdGTP is a terminating substrate for pol I
The results of two experiments suggested that the BuPdG- 1 8mer
was resistant to extension by pol I. Incubation of the 17mer:29mer
primer:template with 100 iaM BuPdGTP and 2 uM dTTP
(Figure 2, lane F) did not result in a product migrating near the
l9mer of lane E, but only the BuPdG-18mer. Similarly,
incubation of synthetic BuPdG-18mer:29mer with 2 ,tM dTTP
did not result in any product (lane G). To determine the extent
of this resistance, the BuPdG-18mer:29mer was incubated with
dTTP and pol I under various conditions. Incubations at
concentrations as high as 100 ,tM dTTP and for up to 60 minutes
at 30°C did not lead to extension of the BuPdG-primer by pol
I (data not shown).
3'-BuPdG primer is resistant to pol I 3' to 5' exonuclease
In control extension reactions of the primer:templates lacking
dNTP substrates, the 17mer primer was partially degraded by
the 3' to 5' exonuclease activity of pol l, but no such degradation
was observed with the BuPdG- 1 8mer (results not shown).
Because exonucleolytic cleavage of single stranded DNA is more
efficient than that of double stranded DNA,'2 we incubated
labelled 17mer and BuPdG-18mer separately with pol I at 30°C
and removed aliquots of the reactions at various times. The
aliquots were subjected to denaturing PAGE with the results
shown in Figure 3. It is clear that the 17mer is degraded to
smaller oligomers with a half life of about 15 minutes and that
essentially none remains after 60 minutes. In contrast, no
demonstrable degradation of the BuPdG-18mer was observed
after incubation for 60 minutes (Figure 3).
BuPdGTP is a weak inhibitor of pol I and protects activated
DNA from exonucleolytic degradation
BuPdGTP was added to assays of pol I with activated DNA in
the presence 25 /tM each of dATP, dCTP and dGTP, and the
incorporation of 10 AM [3H]dTTP into acid-precipitable material
was measured. Only 24% inhibition of label incorporation was
observed at 100 ptM BuPdGTP under these conditions. In
**' *
*~~~~~~~~~~~~~~~~!s
Figure 3. Exonucleolytic cleavage of single stranded primers by pol l. 5,-_32]P-
labelled 17mer and BuPdG-18mer (1.2 tiM) were separately incubated with pol
I in extension buffer (see Materials and Methods) for various periods of time.
and the products were analyzed by 8M urea-PAGE.
contrast, when pol I was assayed in the absence of dGTP (the
truncated assay), BuPdGTP stimulated labelled dTTP
incorporation at low concentrations (Table 1). Because the results
above showed that BuPdGTP is a terminating substrate for pol
I, one would expect either no effect of the compound or inhibition
rather than stimulation of enzyme activity in the truncated assay.
The results are, however, consistent with two possibilities. First,
BuPdGTP may inhibit the 3' to 5' exonuclease activity directly.
This is probably not the case, because BuPdGTP at 100 jzM did
not inhibit exonucleolytic release of [3H]dTMP after incubation
of [3H]-labelled single stranded DNA with pol I (data not
shown). Second, the low level of BuPdGTP incorporation at G-
requiring sites in the absence of dGTP may protect the primers
from 3' to 5' exonuclease degradation; thus the control counts
measured in the absence of dGTP would represent the net
difference between incorporation and removal of nucleotides
when the enzyme is unable to bind the next substrate, i.e. dGTP.
DISCUSSION
BuPdGTP inhibits eukaryotic DNA polymerase a with high
potency (Ki ca. 1 -5 nM), but is not a substrate for the
enzyme.2 Thus its mechanism of inhibition of pol a likely
involves sequestration of the enzyme in a tight, but reversible,
complex consisting of the nucleotide, the primer:template and
the enzyme. Indeed, sequestration experiments have shown that
the latter mechanism pertains not only for BuPdGTP, but for other
non-incorporable DNA polymerase inhibitors.24 We recently
found that the lack of ability to incorporate BuPdGTP was not
shared by another sensitive DNA polymerase, that from the
bacteriophage T4. The T4 enzyme is inhibited with nanomolar
potency by BuPdGTP, but is able to incorporate the analog.2
The need for an authentic 3'-BuPdG oligomer to test hypotheses
about the mechanism(s) of DNA polymerase inhibition by
BuPdGTP prompted the chemical synthesis reported in this paper.
E. coli DNA polymerase I has been considered resistant to
BuPdGTP, based on the weak inhibition (see above) or lack of
inhibition' observed in standard assays of the enzyme. In this
paper we have shown that, in the absence of competing dGTP,
BuPdGTP stimulates residual synthesis catalyzed by pol I in a
truncated assay lacking dGTP, and is a substrate with surprisingly
good affinity for the enzyme. The apparent Km values of 0.8 AM
and 2.0 /tM for dGTP and BuPdGTP in single site extension
reactions (see above) indicate similar affinities of the nucleotides
for the enzyme-primer:template complex. However, the
profoundly reduced incorporation rate of the modified substrate
(see above) explains the apparent resistance of pol I activity
toward the compound in standard assays containing dGTP. These
Table I. Effect of BuPdGTP on E.coli pol I.
pmol [3H]dTMP incorporated(a)
BuPdGTP, 4M + dGTP - dGTP
0 20.8 2.3
1 20.8 3.5
10 17.4 4.7
100 15.8 4.5
(a) Assays were done with activated DNA as described in Materials and Methods.
Standard deviations of duplicate experiments averaged 4 0. I pmol, and background
incorporation in assays lacking enzyme was 0.04 pmol. + dGTP corresponds
to 25 jaM of dGTP, and - dGTP corresponds to the truncated assay.
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results suggest that the BuPdG-primers, when formed, do not
have substantial affinity for the enzyme. In contrast, the high
potency of BuPdGTP for T4 DNA polymerase may result directly
from incorporation of the analog. Our application of the primer
extension reactions and synthetic BuPdG-primer:templates will
help to clarify these issues.
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